PBYI · Puma Biotechnology, Inc. · Debt
$10.66
-0.26 (-2.38%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$563.69M
Shares
51.62M
Volume · Oct 28
108.97K
Avg daily vol (3M)
328.93K
Debt Profile
Completed filing coverage through Jul 29, 2021Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of long-term debt | 2026-06-30 | USD 0 | 10-Q filed 2026-08-06 |
| Noncurrent debt carrying amount | 2026-06-30 | USD 0 | 10-Q filed 2026-08-06 |
| Operating lease liabilities | 2026-06-30 | USD 4,817,000 | 10-Q filed 2026-08-06 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1401667
CUSIP
74587V107
13F (30d)
31 filings
31 filers
Visit website
Investor relations